At a glance
ClinicalIndex Comparison RecordN/ACompleted· 165 enrolled
Drug / intervention
iCAST covered stentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Atrium iCAST Iliac Stent Pivotal Study
In Brief
A clinical study evaluating iCAST covered stent for Peripheral Vascular Disease. Completed, enrolled 165 participants across 25 sites in 2 countries.
Detailed Summary
Prospective, multicenter, non-randomized, single-arm registry to evaluate the safety and effectiveness of the iCAST Covered Stent System in the treatment of patients with symptomatic claudication or rest pain and angiographic confirmation of de novo or restenotic lesions in the common and/or external iliac artery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Vascular Disease
CountriesGermany, United States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2007
First PostedJan 2008
Primary CompletionAug 2011
Study CompletionMay 2014
TodayJul 2026
First PostedJan 15, 2008
Enrollment StartOct 1, 2007
Primary CompletionAug 1, 2011
Study CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 18.5 years ago
Interventions
iCAST covered stentdevice
Iliac stent implantation